Source comparison
CJC-1295 vs Tesamorelin + Ipamorelin Blend: Research Application Comparison
Mechanism GHRH receptor agonist with DAC modification for albumin binding Dual-pathway: GHRH receptor (Tesamorelin) + ghrelin receptor (Ipamorelin) activation Blend mimics endogenous pulsatility; CJC-1295 offers sustained trough elevation Half-Life 6–8 days (p
This comparison does not assign a generated winner or score.
- Mechanism
- GHRH receptor agonist with DAC modification for albumin binding
- Dual-pathway: GHRH receptor (Tesamorelin) + ghrelin receptor (Ipamorelin) activation
- Blend mimics endogenous pulsatility; CJC-1295 offers sustained trough elevation
- Half-Life
- 6–8 days (plasma persistence via albumin binding)
- Tesamorelin ~30 min; Ipamorelin ~2 hours (rapid clearance)
- CJC-1295 suits weekly dosing; blend requires daily administration
- Dosing Frequency
- Every 7–10 days
- Daily (often nocturnal to align with circadian GH pulse)
- Weekly dosing reduces protocol complexity; daily dosing increases precision
- GH Secretion Pattern
- Sustained elevation. Flatter GH curve, reduced peak-to-trough variation
- Pulsatile peaks. 4–6× baseline amplitude within 20–30 minutes, returns to baseline within 2 hours
- Pulsatile pattern aligns with physiological circadian rhythm; sustained pattern supports metabolic consistency
- Receptor Selectivity
- GHRH Type 1 only
- GHRH Type 1 + ghrelin GHS-R1a (no cortisol/prolactin cross-activation)
- Blend's dual pathway reduces somatostatin brake; CJC-1295 avoids ghrelin-mediated appetite signalling
- Reconstituted Stability
- 28 days at 2–8°C
- Tesamorelin 10–14 days; Ipamorelin 21–28 days at 2–8°C
- CJC-1295 offers longer working window; blend requires mid-protocol reconstitution
- Bottom Line
- Best for sustained GH exposure across days. Metabolic studies, long-term tissue remodelling protocols
- Best for mimicking natural GH pulsatility. Acute signalling research, circadian alignment studies
- Choose CJC-1295 for convenience and steady-state kinetics; choose the blend for physiological fidelity and receptor desensitisation studies